Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions

American Journal of Roentgenology

Volumn 175, Issue 4, 2000, Pages 1111-1120

  Pirovano, G ^a   Vanzulli, A ^a   Marti Bonmati, L ^a   Grazioli, L ^a   Manfredi, R ^a   Greco, A ^a   Holzknecht, N ^a   Daldrup Link, H E ^a   Rummeny, E ^a   Hamm, B ^a   Arneson, V ^a   Imperatori, L ^a   Kirchin, M A ^a   Spinazzi, A ^a  

^a Bracco SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE;

ADULT; AGED; CONFERENCE PAPER; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0033797105     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.175.4.1751111     Document Type: Conference Paper

References (35)

1. Primary liver tumors: Diagnosis by MR imaging
2. Detection of liver neoplasms: Techniques and outcomes
3. Hepatic metastases: Basic principles and implications for radiologists
4. Benign hepatic tumors and tumor-like conditions in man
5. Gadolinium chelates with weak binding to serum proteins
6. Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: Results of clinical pharmacologic and pilot imaging studies in non-patient and patient volunteers
7. Pharmacokinetics of Gd-DTPA/dimeglumine after intravenous injection into healthy volunteers
8. Pharmacokinetic behavior of gadoteridol injection
9. Gadobenate dimeglumine - A new contrast agent for MR imaging: Preliminary evaluation in healthy volunteers
10. MultiHance clinical pharmacology: Biodistribution and MR enhancement of the liver
11. Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA) - Preliminary results of phase II clinical application
12. Focal liver lesions: Evaluation of the efficacy of gadobenate dimeglumine in MR imaging - A multicenter phase III clinical study
13. Comparison between high-field-strength MR imaging and CT for screening of hepatic metastases: A receiver operating characteristic analysis
14. Surgical anatomy and anatomical surgery of the liver
15. Radiologic-pathologic correlation in liver tumors
16. Hepatocellular carcinoma: Correlation of MR imaging and histopathologic findings
17. Contrast-enhanced MR imaging of intrahepatic cholangiocarcinoma: Pathologic correlation study
18. Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients
19. Focal liver lesions: Characterization with nonenhanced and dynamic contrast-material-enhanced MR imaging
20. The McNemar test for significance of changes
21. Kappa coefficient calculation using multiple ratings per subject: A special communication
22. Differentiation of hepatic hemangiomas from metastases by dynamic contrast-enhanced MR imaging
23. Liver metastases: Improved detection with dynamic gadolinium-enhanced MR imaging?
24. Hepatic MR imaging with Mn-DPDP: Safety, image quality and sensitivity
25. Hepatic lesions: Detection with ferumoxide-enhanced T1-weighted MR imaging
26. Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: Preliminary results
27. Hepatic tumors: Detection and characterization at IT MR imaging enhanced with AMI-25
28. Gadobenate dimeglumine (Gd-BOPTA): An overview
29. Focal liver disease: Comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T
30. Intrahepatic cholangiocarcinoma: Spin-echo and contrast-enhanced dynamic MR imaging
31. Tumors of the liver and intrahepatic bile ducts
32. Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA)
33. Hepatocellular carcinoma: Correlation between gadobenate dimeglumine-enhanced magnetic resonance (MR) imaging and pathological findings
34. Clinical utility and safety of MultiHance in magnetic resonance imaging of liver cancer: Results of multicenter studies in Europe and the USA